Brontekst bekijken van Stroke prevention therapy in atrial fibrillation patients

== Stroke prevention atrial fibrillation patients ==


[[File:CHA2DS2VASc_score_en_antistoling.JPG]]

== Oral anticoagulation in atrial fibrillation patients with chronic kidney disease ==

[[File:DOAC_Chronic_Kidney_Disease.JPG]]

== Recommendations for stroke prevention in patients with atrial fibrillation ==

[[File:Recommendations_stroke_prevention_AF.JPG]]

== Anticoagulation after a stroke ==

[[File:Anticoagulation_after_a_stroke.JPG]]

== Recommendations for secondary stroke prevention ==

[[File:Recommendations_for_secondary_stroke_prevention.JPG]]

== Initiation anticoagualtion after an intracranial bleed ==

[[File:Initiation_anticoagualtion_after_an_intracranial_bleed.JPG]]

== Recommendations for combination therapy with oral anticoagulants and antiplatelets ==

[[File:Recommendations_for_combination_therapy_with_oral_anticoagulants_and_antiplatelets.JPG]]

== Antithrombotic therapy after an ACS in AF patients requiring anticoagulation ==

[[File:Antithrombotic_therapy_after_an_ACS_in_AF_patients_requiring_anticoagulation.JPG]]

== Anticoagulation: before, during, and after ablation ==

Patients anticoagulated with VKAs should continue therapy during ablation (with an INR of 2–3). Anticoagulation with NOACs is an alternative to warfarin. Anticoagulation should be maintained for at least 8 weeks after ablation for all patients. OAC after catheter ablation should follow general anticoagulation recommendations, regardless of the presumed rhythm outcome.